MARSHALL WACE, LLP - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 56 filers reported holding ONCOCYTE CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q3 2021$225,000
-71.7%
63,216
-54.4%
0.00%
-75.0%
Q2 2021$796,000
-57.2%
138,728
-61.3%
0.00%
-55.6%
Q1 2021$1,861,000
+4797.4%
358,670
+2168.3%
0.01%
Q4 2020$38,000
+18.8%
15,812
+99.9%
0.00%
Q1 2019$32,0007,9100.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2019
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,056,680$15,895,0002.92%
IHT Wealth Management, LLC 200$386,0000.19%
Family Management Corp 22,570$117,0000.08%
Artal Group S.A. 150,000$780,0000.01%
Destination Wealth Management 29,656$154,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$754,0000.01%
Advisor Group, Inc. 102$1,0000.00%
FIFTH THIRD BANCORP 210$1,0000.00%
HUNTINGTON NATIONAL BANK 10$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,233$12,0000.00%
View complete list of ONCOCYTE CORP shareholders